Healthcare Infection Control Practices Advisory Committee (HICPAC), 40703 [2016-14788]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 120 / Wednesday, June 22, 2016 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–14725 Filed 6–21–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK3G9T082PROD with NOTICES
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting for the
aforementioned committee:
Times and Dates: 9:00 a.m.–5:00 p.m.,
EDT, July 14, 2016; 9:00 a.m.–12:00
p.m., EDT, July 15, 2016.
Place: Centers for Disease Control and
Prevention, Global Communications
Center, Building 19, Auditorium B, 1600
Clifton Road NE., Atlanta, Georgia
30333.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 300
people. Please register for the meeting at
www.cdc.gov/hicpac.
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion, the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, the Secretary, Health
and Human Services regarding (1) the
practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters for Discussion: The agenda
will include updates on CDC’s activities
for prevention of healthcare associated
infections (HAIs), updates on
antimicrobial stewardship, an update on
Draft Guideline for Prevention of
Infections in Healthcare Personnel, and
an update from the workgroup for
considerations on endoscope
reprocessing.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Erin Stone, M.S., HICPAC, Division of
VerDate Sep<11>2014
20:02 Jun 21, 2016
Jkt 238001
40703
Healthcare Quality Promotion, NCEZID,
CDC, 1600 Clifton Road NE., Mailstop
A–07, Atlanta, Georgia 30333 Telephone
(404) 639–4045, Email: hicpac@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, Washington, DC 20503 or by fax
to (202) 395–5806. Written comments
should be received within 30 days of
this notice.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Proposed Project
Health Risks from Using Private Wells
for Drinking Water—New — National
Center for Environmental Health
(NCEH), Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2016–14788 Filed 6–21–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–16–16TL]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Background and Brief Description
The Safe Drinking Water Act of 1974
(SDWA) ensures that most Americans
are provided access to water that meets
established public health standards.
However, for over 38 million Americans
who rely on private wells or other
drinking water not protected by the
SDWA (herein referred to as private
wells), that is not the case. There is no
comprehensive knowledge about the
locations of private wells, the
populations served by these sources,
potential contaminants that might be
present in private well water in specific
areas of the country, or the potential
health risks associated with drinking
water from these sources.
The purpose of this new generic
clearance information collection request
is to assess the health risks associated
with exposure to contaminants in
drinking water from private wells across
varied geographic areas of the United
States in partnership with the
requesting agency (state, territorial,
local, or tribal health department). The
information obtained from these
investigations will be used to describe
health risks from exposure to
contaminants in drinking water from
private wells within a defined time
period and geographic distribution. This
information will be used to inform
public health protection activities
conducted by the requesting agencies.
The respondents are defined as adults
at least 18 years old, who use private
wells for drinking water, who are
willing to receive and return a tap water
sampling kit and urine specimen kit or
to provide a blood specimen, and who
are willing to answer survey questions.
They will be recruited from geographic
areas of interest as defined by the
requesting agency.
Based on our historical activities, we
estimate that CDC will conduct up to 10
E:\FR\FM\22JNN1.SGM
22JNN1
]]>Agencies
[Federal Register Volume 81, Number 120 (Wednesday, June 22, 2016)]
[Notices]
[Page 40703]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-14788]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announce the following meeting for the aforementioned
committee:
Times and Dates: 9:00 a.m.-5:00 p.m., EDT, July 14, 2016; 9:00
a.m.-12:00 p.m., EDT, July 15, 2016.
Place: Centers for Disease Control and Prevention, Global
Communications Center, Building 19, Auditorium B, 1600 Clifton Road
NE., Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 300 people. Please register
for the meeting at www.cdc.gov/hicpac.
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion, the
Director, National Center for Emerging and Zoonotic Infectious Diseases
(NCEZID), the Director, CDC, the Secretary, Health and Human Services
regarding (1) the practice of healthcare infection prevention and
control; (2) strategies for surveillance, prevention, and control of
infections, antimicrobial resistance, and related events in settings
where healthcare is provided; and (3) periodic updating of CDC
guidelines and other policy statements regarding prevention of
healthcare-associated infections and healthcare-related conditions.
Matters for Discussion: The agenda will include updates on CDC's
activities for prevention of healthcare associated infections (HAIs),
updates on antimicrobial stewardship, an update on Draft Guideline for
Prevention of Infections in Healthcare Personnel, and an update from
the workgroup for considerations on endoscope reprocessing.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Erin Stone, M.S., HICPAC,
Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton
Road NE., Mailstop A-07, Atlanta, Georgia 30333 Telephone (404) 639-
4045, Email: hicpac@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2016-14788 Filed 6-21-16; 8:45 am]
BILLING CODE 4163-18-P
